Accessibility Menu
Chimerix logo

Chimerix

(NASDAQ) CMRX

Current PriceN/A
Market CapN/A
Since IPO (2013)-55%
5 Year+437%
1 Year+845%
1 Month+1%

Chimerix Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$212.00K

Net Income (TTM)

$88.39M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CMRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Chimerix

Industry

Biotechnology

Employees

81

CEO

Michael T. Andriole, MBA

Headquarters

Durham, NC 27713, US

CMRX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-595%

Net Income Margin

-552%

Return on Equity

-36%

Return on Capital

-40%

Return on Assets

-31%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$212.00K

Operating Income

$96.57M

EBITDA

$96.47M

Operating Cash Flow

$74.98M

Capital Expenditure

$287.00K

Free Cash Flow

$75.26M

Cash & ST Invst.

$31.05M

Total Debt

$458.00K

Chimerix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$57.00K

+1325.0%

Gross Profit

$57.00K

+100.3%

Gross Margin

100.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

79

N/A

Net Income

$22.95M

-26.4%

EBITDA

$24.52M

-18.0%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$131.19M

-27.7%

Accounts Receivable

$812.00K

-28.8%

Inventory

$0.00

N/A

Long Term Debt

$458.00K

-64.8%

Short Term Debt

$0.00

N/A

Return on Assets

-31.39%

N/A

Return on Invested Capital

-40.40%

N/A

Free Cash Flow

$19.43M

+54.4%

Operating Cash Flow

$19.27M

-32.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CDMOAvid Bioservices, Inc.
$12.49+0.00%
ICVXIcosavax, Inc.
$15.31-0.91%
ICPTIntercept Pharmaceuticals, Inc.
$19.00+0.21%
ASLNASLAN Pharmaceuticals Limited
$0.60-14.27%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
IBITiShares Bitcoin Trust
$39.82-0.01%
QQQInvesco QQQ Trust
$593.02-0.00%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$87.49+0.01%

Questions About CMRX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.